Analyst Price Target is $40.11
▲ +56.68% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for AdaptHealth in the last 3 months. The average price target is $40.11, with a high forecast of $50.00 and a low forecast of $30.00. The average price target represents a 56.68% upside from the last price of $25.60.
Current Consensus is
The current consensus among 10 investment analysts is to buy stock in AdaptHealth. This rating has held steady since June 2020, when it changed from a Hold consensus rating.
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.